The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 06, 2007

Filed:

Mar. 17, 2003
Applicants:

Roelof W. Feenstra, Weesp, NL;

Josephus H. M. Lange, Weesp, NL;

Maria L. Pras-raves, Weesp, NL;

Cornelis G. Kruse, Weesp, NL;

Herman H. Van Stuivenberg, Weesp, NL;

Tinka Tuinstra, Weesp, NL;

Hiskias Keizer, Weesp, NL;

Inventors:

Roelof W. Feenstra, Weesp, NL;

Josephus H. M. Lange, Weesp, NL;

Maria L. Pras-Raves, Weesp, NL;

Cornelis G. Kruse, Weesp, NL;

Herman H. van Stuivenberg, Weesp, NL;

Tinka Tuinstra, Weesp, NL;

Hiskias Keizer, Weesp, NL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/415 (2006.01); C07D 231/04 (2006.01); C07D 401/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to a group of novel 2,3 diaryl-pyparazolidine derivatives having formula (1). The symbols used in formula (1) have the meanings given in the specification. The compounds have inhibiting activity on enzymes which degrade the neuropeptide neurotensin and can be used for the treatment of affections and diseases caused by disturbances of the neurotensin mediated transmission.


Find Patent Forward Citations

Loading…